Skip to main content
. 2023 Mar 3;10:1077896. doi: 10.3389/fnut.2023.1077896

Table 3.

Stratified analyses of the associations between HEI-2010 scores and all-cause mortality among participants with hypertension.

Characteristic HEI-2010 scores HR (95% CI) a P-trend P-interactionb
Q1 14.0–44.1 Q2 44.1–53.9 Q3 53.9–64.1 Q4 64.1–98.8
Age, y 0.649
<60 (n = 3,205) 1.00 0.90 (0.59, 1.37) 0.83 (0.52, 1.33) 0.78 (0.44, 1.39) 0.338
≥60 (n = 3,485) 1.00 0.83 (0.68, 1.00) 0.83 (0.65, 1.06) 0.73 (0.57, 0.93) 0.034
Sex 0.090
Women (n = 3,471) 1.00 0.96 (0.73, 1.26) 0.82 (0.61, 1.10) 0.81 (0.58, 1.14) 0.161
Men (n = 3,219) 1.00 0.75 (0.57, 0.98) 0.78 (0.62, 1.00) 0.59 (0.42, 0.83) 0.002
Ethnicity 0.961
Non-Hispanic white (n = 2,922) 1.00 0.83 (0.68, 1.03) 0.76 (0.60, 0.97) 0.66 (0.49, 0.88) 0.003
Others (n = 3,768) 1.00 0.76 (0.58, 0.98) 0.78 (0.57, 1.07) 0.69 (0.50, 0.94) 0.040
Education 0.617
Below/high school (n = 3,611) 1.00 0.81 (0.66, 1.00) 0.87 (0.66, 1.13) 0.81 (0.62, 1.06) 0.216
Above high school (n = 3,039) 1.00 0.88 (0.62, 1.23) 0.68 (0.46, 1.01) 0.56 (0.39, 0.82) 0.001
BMI, kg/m2 0.793
<30 (n = 3,319) 1.00 0.97 (0.74, 1.27) 0.86 (0.64, 1.16) 0.70 (0.52, 0.93) 0.011
≥30 (n = 3,371) 1.00 0.72 (0.56, 0.93) 0.66 (0.49, 0.88) 0.70 (0.49, 1.00) 0.043
Recreational activity 0.126
Inactive (n = 4,060) 1.00 0.87 (0.72, 1.04) 0.87 (0.70, 1.01) 0.75 (0.59, 0.96) 0.025
Active (n = 2,630) 1.00 0.69 (0.46, 1.03) 0.51 (0.34, 0.77) 0.50 (0.32, 0.77) 0.002
Drinking status 0.660
Non-drinker (n = 2,671) 1.00 0.69 (0.54, 0.88) 0.70 (0.55, 0.88) 0.64 (0.49, 0.84) 0.003
Drinker (n = 4,019) 1.00 0.97 (0.72, 1.31) 0.86 (0.62, 1.18) 0.67 (0.48, 0.92) 0.006
Smoking status 0.022
Never (n = 3,452) 1.00 0.61 (0.46, 0.82) 0.70 (0.54, 0.92) 0.59 (0.43, 0.81) 0.0139
Former/Current (n = 3,238) 1.00 0.93 (0.75, 1.16) 0.76 (0.59, 0.97) 0.62 (0.46, 0.84) <0.001
Hyperlipidemia 0.132
No (n = 1,331) 1.00 0.56 (0.34, 0.94) 0.82 (0.51, 1.31) 0.50 (0.30, 0.85) 0.036
Yes (n = 5,359) 1.00 0.87 (0.69, 1.09) 0.75 (0.59, 0.96) 0.71 (0.54, 0.93) 0.007
Diabetes 0.444
No (n = 4,611) 1.00 0.78 (0.61, 0.98) 0.72 (0.55, 0.94) 0.64 (0.48, 0.87) 0.007
Yes (n = 2,079) 1.00 0.93 (0.65, 1.31) 0.90 (0.67, 1.20) 0.75 (0.51, 1.10) 0.100
CVD 0.138
No (n = 5,410) 1.00 0.81 (0.66, 1.00) 0.68 (0.54, 0.85) 0.62 (0.47, 0.80) <0.001
Yes (n = 1,280) 1.00 0.86 (0.62, 1.17) 1.02 (0.75, 1.39) 0.84 (0.60, 1.19) 0.516
Blood pressure level 0.910
SBP/DBP <160/100 (n = 5,976) 1.00 0.81 (0.67, 0.98) 0.79 (0.64, 0.98) 0.71 (0.56, 0.91) 0.007
SBP/DBP ≥ 160/100 (n = 714) 1.00 0.88 (0.47, 1.67) 0.71 (0.42, 1.22) 0.50 (0.28, 0.91) 0.011
Anti-hypertensive drug use 0.664
No (n = 5,579) 1.00 0.91 (0.72, 1.15) 0.84 (0.67, 1.06) 0.72 (0.54, 0.95) 0.012
Yes (n = 1,111) 1.00 0.47 (0.29, 0.76) 0.52 (0.34, 0.80) 0.72 (0.54, 0.95) 0.035
a

Data are expressed as HRs (95% CIs) adjusted for age (continuous), sex (men or women), ethnicity (non-Hispanic white, non-Hispanic Black, Mexican American, and other race), education (below high school, high school, and above high school), BMI (continuous), smoking status (never smokers, former smoker, and current smokers), drinking status (non-drinker, low-to-moderate drinker, and heavy drinker), recreational activity (inactive, moderately active, and vigorously active), total energy intakes (in quartiles), blood pressure level (SBP/DBP ≥ 160/100 mmHg or SBP/DBP <160/100 mmHg), anti-hypertensive medicine use (yes or no), hyperlipidemia (yes or no), diabetes (yes or no), and CVD (yes or no). We did not include the strata variable in the model when stratifying by itself.

b

The interaction between continuous HEI-2010 scores and stratification variables was examined using the Wald test.